Researchers at Japan’s Advanced Institute of Science and Technology identified Ewingella americana in the intestines of Japanese tree frogs. In a mouse model of colorectal cancer, one intravenous dose produced complete tumor elimination in all treated animals. The bacterium appeared to attack cancer cells directly while also activating immune responses. However, the findings remain preclinical: the study involved mice, not humans, and used a specific tumor model. Further research is needed to assess safety, effectiveness, and possible clinical applications later.
Published by Banx Network. This article is part of the Banx decentralized media programme, powered by the BXE token on the XRP Ledger.





